Ash Access Technology, Inc. Partners With DaVita Clinical Research To Conduct Pivotal FDA Clinical Trial

Ash Access Technology, Inc., a privately held biomedical and medical device company in Lafayette, Indiana, announced today that it has established an agreement with DaVita Clinical Research (a subsidiary of DaVita Inc.) to conduct the pivotal Food & Drug Administration clinical trial for its flagship antimicrobial/antithrombotic therapy in select dialysis clinics across the United States.

Back to news